Abstract:As a pivotal defensive line against multitudinous malignant tumors, natural killer (NK) cells exist in the tumor microenvironment (TME). RAD18 E3 Ubiquitin Protein Ligase (RAD18) has been reported to foster the malignant progression of multiple cancers, but its effect on NK function has not been mined. Here, the study was designed to mine the mechanism by which RAD18 regulates the killing effect of NK cells on colorectal cancer (CRC) cells. Expression of E2F Transcription Factor 7 (E2F7) and RAD18 in CRC tissues, their correlation, binding sites, and RAD18 enrichment pathway were analyzed by bioinformatics. Expression of E2F7 and RAD18 in cells was assayed by qRT-PCR and western blot. Dual-luciferase assay and chromatin immunoprecipitation (ChIP) assay verified the regulatory relationship between E2F7 and RAD18. CCK-8 assay was utilized to assay cell viability, colony formation assay to detect cell proliferation, lactate dehydrogenase (LDH) test to assay NK cell cytotoxicity, ELISA to assay levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), and immunofluorescence to detect expression of toxic molecules perforin and granzyme B. High expression of RAD18 and E2F7 was found in CRC tissues and cells. Silencing RAD18 could hamper the proliferation of CRC cells, foster viability and cytotoxicity of NK cells, and increase the secretion of GM-CSF, TNF-α, IFN-γ as well as the expression of perforin and granzyme B. Additionally, ChIP and dual-luciferase reporter assay ascertained the binding relationship between RAD18 promoter region and E2F7. E2F7 could activate the transcription of RAD18, and silencing RAD18 reversed the inhibitory effect of E2F7 overexpression on NK cell killing. This work clarified the inhibitory effect of the E2F7/RAD18 axis on NK cell killing in CRC, and proffered a new direction for immunotherapy of CRC in targeted immune microenvironment.

EWS Protein Inhibits the Transcriptional Activity of Nuclear Factor-κB

EWS Inhibits the Transcriptional Activity of IRF3 Stimulated with TRIF and IKKε

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

Transcription factor E2F1 suppresses dendritic cell maturation.

Transcription factor E2F1 suppresses dendritic cell maturation. (167.3)

A Study of Mechanism of Modulation of NF-κB Activity of HepG2 Cells by BC047440 Genes

Positive and Negative Modulation of the Transcriptional Activity of the ETS Factor ESE-1 through Interaction with p300, CREB-binding Protein, and Ku 70/86

[Mutations in Various Functional Domains of HPV2 E2 Protein Inhibit the Transcriptional Depression Activities].

14-3-3Η Inhibits the Transcriptional Activity of IRF3 Stimulated with TRIF and IKKε

E4B Inhibits the Transcriptional Activity of NF-κB

CUEDC1 Inhibits the Transcriptional Activity of AP-1 Stimulated by TNF Α

The Inhibition of TNFα-induced NF-κB Transcriptional Activity by AWP1

Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription

E2F1 represses beta-catenin/TCF activity by direct up-regulation of Siah1.

Nuclear protein IκB-ζ inhibits the activity of STAT3

The Studies on Inhibitory Action of Transfection of NF-κB Suppressor Gene for Bioactivity of Esophageal Carcinoma Cell Line

ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor Β Signaling Through a Direct Interaction with Smad3*

The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2

E2f1 Induces Tumor Cell Survival Via Nuclear Factor-Kappa B-Dependent Induction of Egr1 Transcription in Prostate Cancer Cells

Genome-wide Mapping of RELA(p65) Binding Identifies E2F1 as a Transcriptional Activator Recruited by NF-κB upon TLR4 Activation

E2F1 Suppreses DC Maturation (88.22)